Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
PCI-34051 induces caspase-dependent apoptosis in cell lines derived from T-cell lymphomas or leukemia
Exhibits antitumor activity and stimulates interferon-β secretion in tumors
1993 May 15
64748-79-4
PubMed PMID: 16889941
Entecavir - CAS# 142217-69-4 Catalog No.:M11175-2 PCI-34051 induces caspase-dependent apoptosis inEntecavir is a reverse transcriptase inhibitor. It is an oral antiviral drug used in the treatment of hepatitis B virus (HBV) infection. It prevents the hepatitis B virus from multiplying and reduces the amount of virus in the body. More specifically, it is a deoxyguanosine analogue, that inhibits reverse transcription, DNA replication and transcription in the viral replication process. The chemical classification of entecavir anhydrous is Nucleoside
US$ 158.00
US$ 130.63
US$ 92.00
US$ 211.14
US$ 144.00
US$ 229.00
US$ 149.00